Business Description
Shandong Boan Biotechnology Co Ltd
ISIN : CNE100005RV4
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.48 | |||||
Debt-to-EBITDA | 4.4 | |||||
Interest Coverage | 2.22 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.32 | |||||
Beneish M-Score | -2.41 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 54.1 | |||||
3-Year EPS without NRI Growth Rate | 23.4 | |||||
3-Year FCF Growth Rate | 23.2 | |||||
3-Year Book Growth Rate | 36.2 | |||||
Future 3-5Y EPS without NRI Growth Rate | 29.64 | |||||
Future 3-5Y Total Revenue Growth Rate | 30.34 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.65 | |||||
9-Day RSI | 25.19 | |||||
14-Day RSI | 29.94 | |||||
6-1 Month Momentum % | -2.8 | |||||
12-1 Month Momentum % | -40.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.35 | |||||
Quick Ratio | 1.03 | |||||
Cash Ratio | 0.31 | |||||
Days Inventory | 329.01 | |||||
Days Sales Outstanding | 116.06 | |||||
Days Payable | 408.37 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -5.25 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 74.07 | |||||
Operating Margin % | 6.3 | |||||
Net Margin % | 8.52 | |||||
FCF Margin % | -61.3 | |||||
ROE % | 4.56 | |||||
ROA % | 2.62 | |||||
ROIC % | 2.46 | |||||
ROC (Joel Greenblatt) % | 11.58 | |||||
ROCE % | 4.62 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 67.6 | |||||
PE Ratio without NRI | 67.6 | |||||
PS Ratio | 5.68 | |||||
PB Ratio | 3.12 | |||||
Price-to-Tangible-Book | 15 | |||||
EV-to-EBIT | 52.93 | |||||
EV-to-EBITDA | 28.86 | |||||
EV-to-Revenue | 5.99 | |||||
EV-to-FCF | -10.89 | |||||
Price-to-Graham-Number | 6.43 | |||||
Earnings Yield (Greenblatt) % | 1.89 | |||||
FCF Yield % | -11.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shandong Boan Biotechnology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 92.312 | ||
EPS (TTM) (€) | 0.015 | ||
Beta | 0 | ||
Volatility % | 50.69 | ||
14-Day RSI | 29.94 | ||
14-Day ATR (€) | 0.022555 | ||
20-Day SMA (€) | 0.987 | ||
12-1 Month Momentum % | -40.91 | ||
52-Week Range (€) | 0.89 - 2.06 | ||
Shares Outstanding (Mil) | 535.93 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shandong Boan Biotechnology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shandong Boan Biotechnology Co Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Shandong Boan Biotechnology Co Ltd Frequently Asked Questions
What is Shandong Boan Biotechnology Co Ltd(FRA:UJ9)'s stock price today?
When is next earnings date of Shandong Boan Biotechnology Co Ltd(FRA:UJ9)?
Does Shandong Boan Biotechnology Co Ltd(FRA:UJ9) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |